Lesion network of oculogyric crises maps to brain dopaminergic transcriptomic signature
Brain · 2024
DOI: 10.1093/brain/awae094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Bassam Al-Fatly und 7 weiteren Autor:innen. Beteiligte Einrichtung: Movement Disorders and Neuromodulation Unit, Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate membe…. Hauptthemen laut MEDLINE: Transcriptome, Receptors, Dopamine D2, Ocular Motility Disorders, Brain. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Gefördert von: VolkswagenStiftung.
Abstract (Originalsprache)
Oculogyric crises are acute episodes of sustained, typically upward, conjugate deviation of the eyes. Oculogyric crises usually occur as the result of acute D2-dopamine receptor blockade, but the brain areas causally involved in generating this symptom remain elusive. Here, we used data from 14 previously reported cases of lesion-induced oculogyric crises and employed lesion network mapping to identify their shared connections throughout the brain. This analysis yielded a common network that included basal ganglia, thalamic, and brainstem nuclei, as well as the cerebellum. Comparison of this network with gene expression profiles associated with the dopamine system revealed spatial overlap specifically with the gene coding for dopamine receptor type 2 (DRD2) as defined by a large-scale transcriptomic database of the human brain. Furthermore, spatial overlap with DRD2 and DRD3 gene expression was specific to brain lesions associated with oculogyric crises when contrasted to lesions that led to other movement disorders. Our findings identify a common neural network causally involved in the occurrence of oculogyric crises and provide a pathophysiological link between lesion locations causing this syndrome and its most common pharmacological cause, namely DRD2 blockade.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Movement Disorders and Neuromodulation Unit, Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 1011…
- Center for Brain Circuit Therapeutics, Department of Neurology, Psychiatry, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Brain Modulation Lab, Department of Neurosurgery, Massachusetts General Hospital, Boston, MA 02114, USA.
- SENSE Research Unit, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
- Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Toronto, ON, M5T 2S6, Canada.
- Athinoula A. Martinos Centre for Biomedical Imaging, Department of Neurology and Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA.
ORCID-Profile: Bassam Al-Fatly, Christos Ganos
Förderung
- VolkswagenStiftung
Zitieren
APA
Al-Fatly, B., Neudorfer, C., Kaski, D., Lang, A. E., Kühn, A. A., Fox, M. D., Horn, A., & Ganos, C. (2024). Lesion network of oculogyric crises maps to brain dopaminergic transcriptomic signature. Brain. https://doi.org/10.1093/brain/awae094
Vancouver
Al-Fatly B, Neudorfer C, Kaski D, Lang AE, Kühn AA, Fox MD, et al. Lesion network of oculogyric crises maps to brain dopaminergic transcriptomic signature. Brain. 2024. doi:10.1093/brain/awae094
BibTeX
@article{AlFatly2024,
author = {Al-Fatly, Bassam and Neudorfer, Clemens and Kaski, Diego and Lang, Anthony E and Kühn, Andrea A and Fox, Michael D and Horn, Andreas and Ganos, Christos},
title = {Lesion network of oculogyric crises maps to brain dopaminergic transcriptomic signature},
journal = {Brain},
year = {2024},
doi = {10.1093/brain/awae094}
}
EUVIMED